These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4280255)

  • 1. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 2. The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
    Koutský J; Rybák M; Jirásek JE; Hladovec J; Mansfeld V
    Gynaecologia; 1969; 167(4):265-70. PubMed ID: 5767879
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis and its control.
    Andersson L
    S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
    Avanzi G
    Minerva Med; 1972 Dec; 63(87):4758-66. PubMed ID: 4565687
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antifibrinolytic therapy of gynecologic hemorrhages].
    Koutský J; Padovec J; Jirásek JE; Rybák M; Hladovec J; Mansfeld V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):151-65. PubMed ID: 4174653
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Observation of coagulation factors in memometrorrhagias treated with antifibrinolytic agents].
    Koutský J; Padovec J; Dimitrovová K; Janele J; Kastilová B
    Cesk Gynekol; 1968 Sep; 33(7):492-6. PubMed ID: 5683907
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of juvenile menometrorrhagias by antifibrinolytic agents (author'stransl)].
    Koutský J; Kraus I; Tikovská L
    Cesk Gynekol; 1975 Jun; 40(5):388-9. PubMed ID: 1137900
    [No Abstract]   [Full Text] [Related]  

  • 11. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical study of the changes in endometrial fibrinolytic activity during treatment of menometrorrhagia with anitfbrinolytics.
    Koutský J; Jirásek JE
    Gynaecologia; 1969; 168(4):241-7. PubMed ID: 5310095
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial treatment of genital hemorrhages with Dicynone].
    Gaudefroy M; Debienne-Wibaux A
    J Sci Med Lille; 1968 Oct; 86(10):629-39. PubMed ID: 5757879
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of hemostatic preparations in obstetrical hemorrhages].
    Pavlovskiĭ DP; Mikaĭlenko ET
    Pediatr Akus Ginekol; 1976; (1):33-7. PubMed ID: 787905
    [No Abstract]   [Full Text] [Related]  

  • 16. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
    Valsecchi A; Cappelletti M
    Minerva Ginecol; 1975 Apr; 27(4):339-47. PubMed ID: 1169724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatments of meno-metrorrhagia with hemocaprol (epsilon aminocaproic acid)].
    Malene Y
    Sem Ther; 1964 Oct; 40(8):505. PubMed ID: 5878577
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of fibrinolytic hemorrhage with proteinase inhibitors: a preliminary report.
    Ambrus JL; Ambrus CM; Stutzman L; Shimert G; Niswander KR; Woodruff MW; Magoss IV
    Ann N Y Acad Sci; 1968 Jun; 146(2):625-41. PubMed ID: 4239439
    [No Abstract]   [Full Text] [Related]  

  • 20. Epsilon aminocaproic acid.
    Br Med J; 1967 Dec; 4(5581):725-6. PubMed ID: 6070179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.